Related Experiment Videos
Fulminating subacute sclerosing panencephalitis: case report and literature review
R PeBenito1, S H Naqvi, M M Arca
1Department of Pediatrics, Brookdale University Hospital and Medical Center, Brooklyn, NY 11212-3198, USA.
Abstract:
We describe a young urban boy with atypically fulminant subacute sclerosing panencephalitis (SSPE). He had measles at 3 years of age despite receiving measles immunization in infancy. The literature describing acute SSPE is reviewed and summarized. This report reiterates the need to include SSPE as a diagnostic possibility in acute encephalopathic processes. The dismal prognosis of SSPE further emphasizes the need for measles vaccination and revaccination of all children who are initially immunized at an age of less than 15 months.
Insights
A rare, aggressive form of subacute sclerosing panencephalitis (SSPE) occurred in a vaccinated child. This case highlights the critical importance of measles vaccination and revaccination to prevent this severe neurological disease.
Area of Science:
- Neurology
- Pediatrics
- Infectious Diseases
Background:
- Subacute sclerosing panencephalitis (SSPE) is a rare, progressive neurological complication of measles infection.
- While typically slow-progressing, SSPE can present atypically with fulminant (rapidly progressing) courses.
Observation:
- A case report of a young urban boy with an unusually rapid and severe presentation of SSPE is detailed.
- The patient had a history of measles at age 3, despite receiving infant measles immunization.
Findings:
- This case underscores that SSPE should be considered in the differential diagnosis of acute encephalopathic processes, even in immunized individuals.
- Atypical and fulminant presentations of SSPE can occur, challenging typical diagnostic timelines.
Implications:
- The findings emphasize the critical need for widespread measles vaccination and timely revaccination, especially for children immunized before 15 months of age.
- Early recognition and diagnosis of SSPE are crucial for management, despite its generally poor prognosis.